Cooper Companies | COO - Zinsaufwendungen Für Schuld

Aktienkurs
62.94
Täglich Wechseln
1.60 2.61%
Monatlich
-11.97%
Jährlich
-22.43%
Q2 Prognose
63.04




Zinsaufwendungen Für Schuld Veränderung Datum
Abbott USD 68M 26M 2026-03
Align Technology USD 16.04M 14.04M 2025-12
AtriCure USD 1.33M 17K 2025-09
Avanos Medical USD 1.9M 100K 2025-12
Bausch Health Companies USD 397M 15M 2025-12
Baxter International USD 58M 14M 2025-09
Bayer EUR 675M 87M 2025-12
Becton, Dickinson and Co. USD 153M 2M 2025-12
Boston Scientific USD 90M 0 2026-03
Cooper Companies USD 22.4M 2M 2025-12
Dentsply International USD 22M 1000K 2025-12
Dexcom USD 4.2M 500K 2025-12
Edwards Lifesciences USD 35.9M 2.7M 2025-12
Globus Medical USD 17K 5.1B 2025-12
Haemonetics USD 7.21M 3.14M 2025-09
Inogen 1.03M 384K 2025-03
Insulet USD 9.2M 2.2M 2025-12
Integra LifeSciences USD 23.67M 953K 2025-12
Intuitive Surgical USD 20.11B 58.39B 2026-03
J&J USD 43M 25M 2026-03
Medtronic USD 181M 0 2025-12
Merit Medical Systems USD 6.36M 390K 2025-12
Novartis USD 281M 8M 2025-09
ResMed USD 8.79M 14.55M 2025-09
STAAR Surgical USD 800K 799K 2025-09
Steris USD 14.9M 0 2025-12
Stryker USD 607M 450M 2025-12
Tandem Diabetes Care USD 2.07M 872.58M 2025-12
Teleflex USD 28.15M 3.69M 2025-12
Zimmer Biomet Holdings USD 68.8M 3.1M 2026-03